In vitro platelet aggregation in the investigated subjects, maximal extent (percentage)
| Subject . | Collagen, 4 µg/mL . | Collagen, 20 µg/mL . | Convulxin, 60 ng/mL . | Convulxin, 100 ng/mL . | ADP, 5 μM . | TRAP, 25 μM . | Ristocetin, 1.5 mg/mL . |
|---|---|---|---|---|---|---|---|
| II-2 | 43 | 89 | 43 | 77 | 81 | 61 | 90 |
| I-1 | 97 | nd | 89 | nd | 86 | 100 | 100 |
| I-2 | 70 | nd | 97 | nd | 90 | 100 | 96 |
| Subject . | Collagen, 4 µg/mL . | Collagen, 20 µg/mL . | Convulxin, 60 ng/mL . | Convulxin, 100 ng/mL . | ADP, 5 μM . | TRAP, 25 μM . | Ristocetin, 1.5 mg/mL . |
|---|---|---|---|---|---|---|---|
| II-2 | 43 | 89 | 43 | 77 | 81 | 61 | 90 |
| I-1 | 97 | nd | 89 | nd | 86 | 100 | 100 |
| I-2 | 70 | nd | 97 | nd | 90 | 100 | 96 |
Normal ranges: collagen, 66-88%; convulxin, 70-100%; ADP, 43-76%; TRAP, 70-100%; ristocetin, 67-90%.
nd, not determined.